Showing 3,081 - 3,100 results of 314,780 for search '"2"', query time: 0.42s Refine Results
  1. 3081
  2. 3082
  3. 3083

    CO2 Reforming Characteristics under Visible Light Response of Cr- or Ag-Doped TiO2 Prepared by Sol-Gel and Dip-Coating Process by Akira Nishimura, Go Mitsui, Katsuya Nakamura, Masafumi Hirota, Eric Hu

    Published 2012-01-01
    “…A Cr- or Ag-doped TiO2 film was prepared by sol-gel and dip-coating process and used as the photocatalyst for CO2 reforming under the visible light. …”
    Get full text
    Article
  4. 3084

    Diagnostic Performance between Histidine-Rich Protein 2 (HRP-2), a Rapid Malaria Diagnostic Test and Microscopic-Based Staining Techniques for Diagnosis of Malaria by Jean Baptiste Niyibizi, Emmanuel Kamana Gatera

    Published 2020-01-01
    “…The specificity of RDT (HRP-2) was calculated and found to be 59.2%, whereas the specificity of Giemsa microscopy was 100%. …”
    Get full text
    Article
  5. 3085

    Comparative Study of SiO2, Al2O3, and BeO Ultrathin Interfacial Barrier Layers in Si Metal-Oxide-Semiconductor Devices by J. H. Yum, J. Oh, Todd. W. Hudnall, C. W. Bielawski, G. Bersuker, S. K. Banerjee

    Published 2012-01-01
    “…In this paper, we compare the electrical characteristics of inserting an ultrathin interfacial barrier layer such as SiO2, Al2O3, or BeO between the HfO2 gate dielectric and Si substrate in metal oxide semiconductor capacitors (MOSCAPs) and n-channel inversion type metal oxide semiconductor field effect transistors (MOSFETs). …”
    Get full text
    Article
  6. 3086
  7. 3087

    The crystal structure of 3-([1,1′-biphenyl]-2-yl)-1,2-diphenylbenzo[b]phosphole-1-oxide, C32H23OP by Yuan Chengxiong, Huang Mingqing, Liu Fen, Huang Haiyang

    Published 2022-08-01
    “…C32H23OP, monoclinic, P21/n (no. 14), a = 9.1869(11) Å, b = 27.940(3) Å, c = 9.6992(11) Å, β = 107.422(2)°, V = 2375.4(5) Å3, Z = 4, Rgt(F) = 0.0486, wRref(F2) = 0.1255, T = 296 K.…”
    Get full text
    Article
  8. 3088
  9. 3089

    Factors influencing osteoradionecrosis progression during hyperbaric oxygen therapy: A case study [version 2; peer review: 1 approved, 2 approved with reservations] by Khadija Bahrini, Chaima Zitouni, Sameh Mezri, Hedi Gharsallah, Wiem Boughzala, Mounir Haggui

    Published 2025-01-01
    “…The patients were divided into two groups: Group 1 (n=36) included those with regression or stabilization of ORN, while Group 2 (n=10) comprised patients with worsening lesions. …”
    Get full text
    Article
  10. 3090

    A droplet state prediction method for inkjet printing under small sample conditions based on the two-stage TrAdaBoost.R2 algorithm by Yuanyuan Jia, Xiaoding Cheng, Wenai Song, Yaojian Zhou, Haofan Zhao

    Published 2025-01-01
    “…Seven public ink datasets and self-collected experimental data are grouped together, and the decision tree, AdaBoost.R2, and two-stage TrAdaBoost.R2 algorithms are used, respectively. …”
    Get full text
    Article
  11. 3091
  12. 3092

    “On Water” Sonochemical Multicomponent Synthesis of Novel Bioactive 1,1′-(Aryl)bis(2-(cyclohexylamino)-2-oxoethane-1,1-diyl) Di(alkanoates and benzoates) by Manouchehr Mamaghani, Nosrat O. Mahmoodi, Farhad Shirini, Abbas Azimi-Roshan, Azam Monfared

    Published 2013-01-01
    “…An expeditious, efficient, and ecofriendly ultrasound-promoted synthesis of a series of novel 1,1′-(aryl)bis(2-(cyclohexylamino)-2-oxoethane-1,1-diyl) di(alkanoate and benzoate) derivatives (6a–k), as useful building block candidates for natural products and drugs, is reported. …”
    Get full text
    Article
  13. 3093

    Evaluating the pharmacokinetics and safety of blonanserin tablets and Lonasen®: a randomized, open-label, two-period, two-sequence, self-crossover phase I clinical trial by Bo Qiu, Bo Qiu, Haojing Song, Haojing Song, Xue Sun, Xue Sun, Congyang Ding, Congyang Ding, Runxuan Du, Wanjun Bai, Wanjun Bai, Zhanjun Dong, Zhanjun Dong

    Published 2025-01-01
    “…ObjectiveThis study evaluated the pharmacokinetic and safety profiles of generic and original blonanserin tablets under fasting and postprandial conditions, and the bioequivalence of two formulations to obtain sufficient evidence for abbreviated new drug application.MethodsA randomized, open-label, two-period, two-sequence, self-crossover bioequivalence study was conducted to assess the bioequivalence of the test and reference blonanserin tablets under fasting and postprandial conditions. …”
    Get full text
    Article
  14. 3094

    lncRNA NEAT1 Downregulation Ameliorates the Myocardial Infarction of Mice by Regulating the miR-582-5p/F2RL2 Axis by Zhenhua Wu, Yunpeng Bai, Yujuan Qi, Chao Chang, Yan Jiao, Yaobang Bai, Zhigang Guo

    Published 2022-01-01
    “…This study is aimed at effectively investigating the role of coagulation factor II thrombin receptor like 2 (F2RL2) in myocardial infarction (MI) as well as the upstream regulatory miRNA and lncRNA. …”
    Get full text
    Article
  15. 3095

    A Novel Composite Material Designed from FeSi Powder and Mn0.8Zn0.2Fe2O4 Ferrite by Magdalena Streckova, Radovan Bures, Maria Faberova, Pavel Kurek, Pavla Roupcova, Hynek Hadraba, Vladimir Girman, Jozef Strecka

    Published 2015-01-01
    “…A design of the novel microcomposite material composed of spherical FeSi particles and Mn0.8Zn0.2Fe2O4 ferrite is reported together with a characterization of basic mechanical and electrical properties. …”
    Get full text
    Article
  16. 3096
  17. 3097

    AozC, a zn(II)2Cys6 transcription factor, negatively regulates salt tolerance in Aspergillus oryzae by controlling fatty acid biosynthesis by Wenbin Yu, Zeying Zhao, Yufei Zhang, Yayi Tu, Bin He

    Published 2025-01-01
    “…This environmental challenge necessitates the activation of stress response mechanisms within the fungus. The Zn(II)2Cys6 family of transcription factors, known for their zinc binuclear cluster-containing proteins, are key regulators in fungi, modulating various cellular functions such as stress adaptation and metabolic pathways. …”
    Get full text
    Article
  18. 3098

    Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study by Ken Sugimoto, Tomohiro Katsuya, Kei Kamide, Tomomi Fujisawa, Izumi Shimaoka, Mitsuru Ohishi, Ryuichi Morishita, Toshio Ogihara, Hiromi Rakugi

    Published 2010-01-01
    “…At eight weeks, BP change showed a significant interaction between the A-638G polymorphism of Regulator of G protein signaling-2 (RGS2) gene and treatment with azelnidipine or temocapril. …”
    Get full text
    Article
  19. 3099
  20. 3100